Spots Global Cancer Trial Database for genitourinary cancer
Every month we try and update this database with for genitourinary cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors | NCT04354064 | Healthy Volunte... Prostate Cancer Head and Neck C... Esophageal Canc... Genitourinary C... Sarcoma Breast Cancer Colon Cancer Gastrointestina... Solid Tumor Can... Lung Cancer Skin Cancer Melanoma | 18 Years - | Washington University School of Medicine | ||
| Feasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (PAMCaP) | NCT02583815 | Gastrointestina... Breast Cancer Gynecologic Can... Genitourinary C... Leukemia Lung Cancer Skin Cancer Endocrine Cance... Male Genital Ca... | 18 Years - | University of Texas Southwestern Medical Center | ||
| Impact of COVID-19 on GU Disease | NCT04761107 | COVID-19 Infect... Genitourinary C... Benign Urologic... | 40 Years - | Icahn School of Medicine at Mount Sinai | ||
| Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC) | NCT05629065 | Breast Cancer Gastrointestina... Gynecologic Can... Thoracic Cancer Genitourinary C... | Clinician Nudge... Patient Nudge L... | 18 Years - | Dana-Farber Cancer Institute | |
| Adapting the Tumor Board Model for Mental Illness and Cancer | NCT05837598 | Cancer Severe Major De... Schizophrenia Bipolar Disorde... Lung Cancer Breast Cancer Head and Neck C... Gastrointestina... Genitourinary C... | Virtual Cancer ... | 18 Years - | Massachusetts General Hospital | |
| Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention | NCT06168825 | Cancer Breast Cancer Brain Cancer Central Nervous... Colorectal Canc... Esophageal Canc... Gynecologic Can... Head and Neck C... Gastrointestina... Genitourinary C... Melanoma Blood Cancer Lung Cancer Acceptance and ... Mind-Body Thera... Psychosocial In... | Mind Over Matte... | 18 Years - | Inova Health Care Services | |
| An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer | NCT03794635 | Metastatic Canc... Locally Advance... Thoracic Cancer Gynecologic Can... Genitourinary C... Lymphoma | Weekly 45 minut... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast | NCT00147238 | Bladder Cancer Genitourinary C... Prostate Cancer | Ferumoxtran-10 ... MR lymphangiogr... | - | M.D. Anderson Cancer Center | |
| Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer | NCT00120939 | Breast Neoplasm... Ovarian Neoplas... Prostatic Neopl... Lung Neoplasms Gastrointestina... | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
| Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC) | NCT02060370 | Genitourinary C... Kidney Cancer | Sunitinib Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity | NCT04273061 | Breast Cancer Lung Cancer Gastrointestina... Genitourinary C... Gynecologic Can... Sarcoma Unknown Primary... Head and Neck C... Skin Cancer | Atezolizumab | 18 Years - | British Columbia Cancer Agency | |
| Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers | NCT01375699 | Breast Cancer Gastrointestina... Genitourinary C... Sarcoma Gynecologic Can... | Doxorubicin Sildenafil | 18 Years - | Virginia Commonwealth University | |
| An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer | NCT03794635 | Metastatic Canc... Locally Advance... Thoracic Cancer Gynecologic Can... Genitourinary C... Lymphoma | Weekly 45 minut... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Next Generation pErsonalized tX(Therapy) With Plasma DNA Trial-2 in Refractory Solid Tumors (The NEXT-2 Trial) | NCT02140463 | Metastatic Gast... Genitourinary C... | 20 Years - | Samsung Medical Center | ||
| Integrated Molecular Profiling in Advanced Cancers Trial | NCT01505400 | Breast Cancer Non-small Cell ... Colorectal Canc... Genitourinary C... Pancreatobiliar... Upper Aerodiges... Gynecological C... Melanoma Cancer... Rare Cancers Unknown Primary... | 18 Years - | University Health Network, Toronto | ||
| VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy | NCT05920343 | Venous Thromboe... Urologic Cancer | Rivaroxaban 10 ... Placebo control | 18 Years - | Ottawa Hospital Research Institute | |
| Ontario-wide Cancer TArgeted Nucleic Acid Evaluation | NCT02906943 | Breast Cancer Lung Cancer Colorectal Canc... Melanoma Gynecological C... Genitourinary C... Pancreatobiliar... Gastrointestina... Head and Neck C... Rare Cancer Unknown Primary... | 18 Years - | University Health Network, Toronto | ||
| Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC) | NCT02060370 | Genitourinary C... Kidney Cancer | Sunitinib Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer | NCT00120939 | Breast Neoplasm... Ovarian Neoplas... Prostatic Neopl... Lung Neoplasms Gastrointestina... | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
| The Target Urine VOCs Biosensor for Genitourinary Malignancy Detection | NCT06211010 | The Phenomenon ... | the semiconduct... | 16 Years - | Suranaree University of Technology | |
| Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention | NCT06168825 | Cancer Breast Cancer Brain Cancer Central Nervous... Colorectal Canc... Esophageal Canc... Gynecologic Can... Head and Neck C... Gastrointestina... Genitourinary C... Melanoma Blood Cancer Lung Cancer Acceptance and ... Mind-Body Thera... Psychosocial In... | Mind Over Matte... | 18 Years - | Inova Health Care Services | |
| Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer | NCT00120939 | Breast Neoplasm... Ovarian Neoplas... Prostatic Neopl... Lung Neoplasms Gastrointestina... | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
| Personal Web Page In Clinical Trial Participant Education | NCT03887091 | Prostate Cancer Kidney Cancer Genitourinary C... | Postwire | 18 Years - | Dana-Farber Cancer Institute | |
| VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy | NCT05920343 | Venous Thromboe... Urologic Cancer | Rivaroxaban 10 ... Placebo control | 18 Years - | Ottawa Hospital Research Institute | |
| Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass | NCT01433302 | Breast Cancer Genitourinary C... Malignant Femal... Melanoma Sarcoma | Punch Biopsy | 18 Years - | M.D. Anderson Cancer Center | |
| Next Generation pErsonalized tX(Therapy) With Plasma DNA Trial-2 in Refractory Solid Tumors (The NEXT-2 Trial) | NCT02140463 | Metastatic Gast... Genitourinary C... | 20 Years - | Samsung Medical Center | ||
| Ontario-wide Cancer TArgeted Nucleic Acid Evaluation | NCT02906943 | Breast Cancer Lung Cancer Colorectal Canc... Melanoma Gynecological C... Genitourinary C... Pancreatobiliar... Gastrointestina... Head and Neck C... Rare Cancer Unknown Primary... | 18 Years - | University Health Network, Toronto | ||
| Next Generation pErsonalized tX(Therapy) With Plasma DNA Trial-2 in Refractory Solid Tumors (The NEXT-2 Trial) | NCT02140463 | Metastatic Gast... Genitourinary C... | 20 Years - | Samsung Medical Center | ||
| A Feasibility Trial of Geriatric Assessment and Management for Older Cancer Patients | NCT02222259 | Breast Cancer Gastrointestina... Genitourinary C... | GA and Integrat... | 70 Years - | University of Toronto | |
| Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer | NCT03480152 | Melanoma Colon Cancer Gastrointestina... Genitourinary C... Hepatocellular ... | National Cancer... | 18 Years - 70 Years | National Institutes of Health Clinical Center (CC) | |
| Bintrafusp Alfa (M7824) and NHS-IL12 (M9241) Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies | NCT04235777 | Urothelial Canc... Bladder Cancer Genitourinary C... Urogenital Neop... Urogenital Canc... | M7824 M9241 Stereotactic bo... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer | NCT03794635 | Metastatic Canc... Locally Advance... Thoracic Cancer Gynecologic Can... Genitourinary C... Lymphoma | Weekly 45 minut... | 18 Years - | Memorial Sloan Kettering Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
